FDA issued a draft guidance with recommendations for feasibility and early feasibility clinical studies for devices intended to improve glycemic control in patients with Type 2 diabetes.
Read more: FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes